UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Assessment of fludarabine plus cyclophosphamide for patients with chronic lymphocytic leukaemia (the LRF CLL4 Trial): a randomised controlled trial

The Lancet (British edition), 2007-07, Vol.370 (9583), p.230-239

2007

Volltextzugriff (PDF)

The configuration of the immunoglobulin genes in B cell chronic lymphocytic leukemia

Leukemia, 2002-06, Vol.16 (6), p.973-984

2002

Volltextzugriff (PDF)

Ofatumumab As Single-Agent CD20 Immunotherapy in Fludarabine-Refractory Chronic Lymphocytic Leukemia

Journal of clinical oncology, 2010-04, Vol.28 (10), p.1749-1755

2010

Volltextzugriff (PDF)

Long-term follow-up of patients with CLL treated with the selective Bruton's tyrosine kinase inhibitor ONO/GS-4059

Blood, 2017-05, Vol.129 (20), p.2808-2810

2017

Volltextzugriff (PDF)

Detection of translocations affecting the BCL6 locus in B cell non-Hodgkin's lymphoma by interphase fluorescence in situ hybridization

Leukemia, 2001-09, Vol.15 (9), p.1475-1484

2001

Volltextzugriff (PDF)

Eμ miR-125b transgenic mice develop lethal B-cell malignancies

Leukemia, 2011-12, Vol.25 (12), p.1849-1856

2011

Volltextzugriff (PDF)

Nonpegylated liposomal doxorubicin (Myocet™) combination (R-COMP) chemotherapy in elderly patients with diffuse large B-cell lymphoma (DLBCL): results from the phase II EUR018 trial

Annals of oncology, 2010-07, Vol.21 (7), p.1492-1499

2010

Volltextzugriff (PDF)

Apoptosis induced by histone deacetylase inhibitors in leukemic cells is mediated by Bim and Noxa

Leukemia, 2007-08, Vol.21 (8), p.1773-1782

2007

Volltextzugriff (PDF)

ATM is usually rearranged in T-cell prolymphocytic leukaemia

Oncogene, 1998-02, Vol.16 (6), p.789-796

1998

Volltextzugriff (PDF)

Lack of somatic hypermutation of IG VH genes in lymphoid malignancies with t(2;14)(p13;q32) translocation involving the BCL11A gene

Leukemia, 2002-05, Vol.16 (5), p.937-939

2002

Volltextzugriff (PDF)

The role of immunoglobulin translocations in the pathogenesis of B-cell malignancies

Blood, 2000-08, Vol.96 (3), p.808-822

2000

Volltextzugriff (PDF)

TRAIL receptor-selective mutants signal to apoptosis via TRAIL-R1 in primary lymphoid malignancies

Cancer research (Chicago, Ill.), 2005-12, Vol.65 (24), p.11265-11270

2005

Volltextzugriff (PDF)

Histone deacetylase inhibitors potentiate TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in lymphoid malignancies

Cell death and differentiation, 2004-12, Vol.11 (S2), p.S193-S206

2004

Volltextzugriff (PDF)

Management guidelines for the use of alemtuzumab in chronic lymphocytic leukemia

Leukemia, 2009-11, Vol.23 (11), p.1980-1988

2009

Volltextzugriff (PDF)

The impact of follicular lymphoma on health-related quality of life

Annals of oncology, 2008-03, Vol.19 (3), p.570-576

2008

Volltextzugriff (PDF)

Mantle-cell lymphoma genotypes identified with CGH to BAC microarrays define a leukemic subgroup of disease and predict patient outcome

Blood, 2005-06, Vol.105 (11), p.4445-4454

2005

Volltextzugriff (PDF)

Downregulation of Mcl-1 potentiates HDACi-mediated apoptosis in leukemic cells

Leukemia, 2008-04, Vol.22 (4), p.819-825

2008

Volltextzugriff (PDF)

Chronic lymphocytic leukemic cells exhibit apoptotic signaling via TRAIL-R1

Cell death and differentiation, 2005-07, Vol.12 (7), p.773-782

2005

Volltextzugriff (PDF)

Transformation of follicular lymphoma to diffuse large cell lymphoma is associated with a heterogeneous set of DNA copy number and gene expression alterations

Blood, 2003-04, Vol.101 (8), p.3109-3117

2003

Volltextzugriff (PDF)

Ofatumumab retreatment and maintenance in fludarabine‐refractory chronic lymphocytic leukaemia patients

British journal of haematology, 2015-07, Vol.170 (1), p.40-49

2015

Volltextzugriff (PDF)

High remission rate in T-cell prolymphocytic leukemia with CAMPATH-1H

Blood, 2001-09, Vol.98 (6), p.1721-1726

2001

Volltextzugriff (PDF)

The BCL11 gene family: involvement of BCL11A in lymphoid malignancies

Blood, 2001-12, Vol.98 (12), p.3413-3420

2001

Volltextzugriff (PDF)

B cell prolymphocytic leukaemia (B-PLL) with complex karyotype and concurrent abnormalities of the p53 and c-MYC gene

Leukemia, 1999-06, Vol.13 (6), p.873-876

1999

Volltextzugriff (PDF)

Characterization of 8p21.3 chromosomal deletions in B-cell lymphoma: TRAIL-R1 and TRAIL-R2 as candidate dosage-dependent tumor suppressor genes

Blood, 2005-11, Vol.106 (9), p.3214-3222

2005

Volltextzugriff (PDF)

Mechanisms of resistance to TRAIL-induced apoptosis in primary B cell chronic lymphocytic leukaemia

Oncogene, 2002-10, Vol.21 (44), p.6809-6818

2002

Volltextzugriff (PDF)

1 – 25 von 133

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(129)
Mit Volltextzugriff
(118)

Publikationsform

Artikel
(126)
Tagungsberichte
(7)

Sprache

Englisch
(133)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(116)
Science & Technology
(116)
Humans
(106)
Biological And Medical Sciences
(74)
Medical Sciences
(72)
Hematology
(70)
Hematologic And Hematopoietic Diseases
(60)
Oncology
(58)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(57)
Male
(39)
Female
(38)
Aged
(35)
Middle Aged
(35)
Translocation, Genetic
(28)
Molecular Sequence Data
(26)
Leukemia
(24)
Adult
(23)
Tumor Cells, Cultured
(23)
Base Sequence
(22)
Lymphoma, B-Cell - Genetics
(19)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Assessment of fludarabine plus cyclophosphamide for patients with chronic lymphocytic leukaemia (the LRF CLL4 Trial): a randomised controlled trial

The configuration of the immunoglobulin genes in B cell chronic lymphocytic leukemia

Ofatumumab As Single-Agent CD20 Immunotherapy in Fludarabine-Refractory Chronic Lymphocytic Leukemia

Long-term follow-up of patients with CLL treated with the selective Bruton's tyrosine kinase inhibitor ONO/GS-4059

Detection of translocations affecting the BCL6 locus in B cell non-Hodgkin's lymphoma by interphase fluorescence in situ hybridization

Eμ miR-125b transgenic mice develop lethal B-cell malignancies

Nonpegylated liposomal doxorubicin (Myocet™) combination (R-COMP) chemotherapy in elderly patients with diffuse large B-cell lymphoma (DLBCL): results from the phase II EUR018 trial

Apoptosis induced by histone deacetylase inhibitors in leukemic cells is mediated by Bim and Noxa

ATM is usually rearranged in T-cell prolymphocytic leukaemia

Lack of somatic hypermutation of IG VH genes in lymphoid malignancies with t(2;14)(p13;q32) translocation involving the BCL11A gene

The role of immunoglobulin translocations in the pathogenesis of B-cell malignancies

TRAIL receptor-selective mutants signal to apoptosis via TRAIL-R1 in primary lymphoid malignancies

Histone deacetylase inhibitors potentiate TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in lymphoid malignancies

Management guidelines for the use of alemtuzumab in chronic lymphocytic leukemia

The impact of follicular lymphoma on health-related quality of life

Mantle-cell lymphoma genotypes identified with CGH to BAC microarrays define a leukemic subgroup of disease and predict patient outcome

Downregulation of Mcl-1 potentiates HDACi-mediated apoptosis in leukemic cells

Chronic lymphocytic leukemic cells exhibit apoptotic signaling via TRAIL-R1

Transformation of follicular lymphoma to diffuse large cell lymphoma is associated with a heterogeneous set of DNA copy number and gene expression alterations

Ofatumumab retreatment and maintenance in fludarabine‐refractory chronic lymphocytic leukaemia patients

High remission rate in T-cell prolymphocytic leukemia with CAMPATH-1H

The BCL11 gene family: involvement of BCL11A in lymphoid malignancies

B cell prolymphocytic leukaemia (B-PLL) with complex karyotype and concurrent abnormalities of the p53 and c-MYC gene

Characterization of 8p21.3 chromosomal deletions in B-cell lymphoma: TRAIL-R1 and TRAIL-R2 as candidate dosage-dependent tumor suppressor genes

Mechanisms of resistance to TRAIL-induced apoptosis in primary B cell chronic lymphocytic leukaemia

Suchergebnisse filtern